Moreover, a Phase 2b clinical trial of a developmental TB vaccine found that immune activation characterized by increased HLA-DR expression on CD4+ T cells was linked to a higher risk of TB disease in South African infants, underscoring how immune activation—potentially driven by CMV—may influence TB disease progression (24). Here, CD4 is linked to tuberculosis.